Sveriges mest populära poddar
Biotech 2050 Podcast
Vetenskap

15. David Mace, Co-Founder and CEO, SwiftScale Biologics

29 min•27 maj 2020
David Mace is the Co-founder & CEO of SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerates time to market for protein drugs by turning a labor-intensive drug production scale-up challenge into a computational challenge. Previously David was an Entrepreneur in Residence at 8VC, where he focused on the intersection of biology & computer science. He is a graduate of the California Institute of Technology.

Fler avsnitt av Biotech 2050 Podcast

Visa alla avsnitt av Biotech 2050 Podcast
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
•23 min
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
•14 min
Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders
•40 min
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
•25 min
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
•27 min
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
•22 min
Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
•31 min
Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth
•13 min
Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech
•34 min
Jay Hartenbach, President & COO, Diakonos Oncology on Reprogramming Cancer Immunity Breakthrough
•28 min

Biotech 2050 Podcast med Biotech 2050 finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.